00876 Relative Valuation
00876's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, 00876 is overvalued; if below, it's undervalued.
Historical Valuation
KAISA HEALTH (00876) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of KAISA HEALTH (00876) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.09
Fair
0.00
PE
1Y
3Y
5Y
0.00
EV/EBITDA
KAISA HEALTH. (00876) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
KAISA HEALTH. (00876) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
KAISA HEALTH. (00876) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
KAISA HEALTH. (00876) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
KAISA HEALTH. (00876) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
KAISA HEALTH (00876) has a current Price-to-Book (P/B) ratio of 0.95. Compared to its 3-year average P/B ratio of 0.38 , the current P/B ratio is approximately 148.42% higher. Relative to its 5-year average P/B ratio of 0.62, the current P/B ratio is about 52.25% higher. KAISA HEALTH (00876) has a Forward Free Cash Flow (FCF) yield of approximately -7.46%. Compared to its 3-year average FCF yield of -31.00%, the current FCF yield is approximately -75.92% lower. Relative to its 5-year average FCF yield of -28.72% , the current FCF yield is about -74.02% lower.
0.95
P/B
Median3y
0.38
Median5y
0.62
-7.46
FCF Yield
Median3y
-31.00
Median5y
-28.72
Performance Decomposition
1Y
3Y
5Y
Market capitalization of 00876 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 00876 in the past 1 year is driven by Unknown.
People Also Watch
MSFT
Microsoft Corp
478.11USD
-1.11%
AVGO
Broadcom Inc
332.48USD
-3.21%
META
Meta Platforms Inc
646.06USD
-0.41%
WMT
Walmart Inc
113.07USD
0.31%
XOM
Exxon Mobil Corp
122.91USD
3.73%
AMZN
Amazon.com Inc
246.26USD
1.95%
ORCL
Oracle Corp
189.65USD
-1.65%
AAPL
Apple Inc
259.04USD
-0.50%
NVDA
NVIDIA Corp
185.04USD
-2.15%
TSLA
Tesla Inc
435.8USD
1.02%
Frequently Asked Questions
Is KAISA HEALTH (00876) currently overvalued or undervalued?
KAISA HEALTH (00876) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of KAISA HEALTH (00876) is between to according to relative valuation methord.
What is KAISA HEALTH (00876) fair value?
00876's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of KAISA HEALTH (00876) is between to according to relative valuation methord.
How does 00876's valuation metrics compare to the industry average?
The average P/S ratio for 00876's competitors is , providing a benchmark for relative valuation. KAISA HEALTH Corp (00876) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for KAISA HEALTH (00876) as of Jan 08 2026?
As of Jan 08 2026, KAISA HEALTH (00876) has a P/B ratio of 0.95. This indicates that the market values 00876 at 0.95 times its book value.
What is the current FCF Yield for KAISA HEALTH (00876) as of Jan 08 2026?
As of Jan 08 2026, KAISA HEALTH (00876) has a FCF Yield of -7.46%. This means that for every dollar of KAISA HEALTH’s market capitalization, the company generates -7.46 cents in free cash flow.
What is the current Forward P/E ratio for KAISA HEALTH (00876) as of Jan 08 2026?
As of Jan 08 2026, KAISA HEALTH (00876) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of KAISA HEALTH’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for KAISA HEALTH (00876) as of Jan 08 2026?
As of Jan 08 2026, KAISA HEALTH (00876) has a Forward P/S ratio of 0.00. This means the market is valuing 00876 at $0.00 for every dollar of expected revenue over the next 12 months.